Cutera (NASDAQ:CUTR) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research note released on Friday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Performance

Shares of NASDAQ:CUTR opened at $0.04 on Friday. The company has a 50 day moving average price of $0.20 and a two-hundred day moving average price of $0.39. The company has a market capitalization of $787,254.00, a PE ratio of -0.01 and a beta of 1.36. Cutera has a 52 week low of $0.09 and a 52 week high of $3.00.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP acquired a new position in shares of Cutera, Inc. (NASDAQ:CUTR) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera as of its most recent SEC filing. Institutional investors and hedge funds own 90.70% of the company’s stock.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.